These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Use of the combination product ipratropium and albuterol in chronic obstructive pulmonary disease. Crouch MA; Raney CR; Davis K Arch Intern Med; 1999 Jul; 159(13):1501-2. PubMed ID: 10399906 [No Abstract] [Full Text] [Related]
13. Bronchodilator therapy of COPD. A reanalysis suggests new roles and new concerns. Deffebach ME Chest; 1996 Jul; 110(1):5-6. PubMed ID: 8681663 [No Abstract] [Full Text] [Related]
14. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. Pillet O; Manier G; Castaing Y Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900 [TBL] [Abstract][Full Text] [Related]
15. [Ipratropium bromide in COPD. Cost effectiveness of the treatment of COPD with ipratropium bromide]. Puig X Aten Primaria; 1995 Mar; 15(4):208. PubMed ID: 7703328 [No Abstract] [Full Text] [Related]
20. The complementary effects of an anticholinergic and sympathicomimetic drug inhalation in patients with severe chronic obstructive lung disease. Sergysels R; Schandevyl W; Yernault JC; Hennebert A Acta Tuberc Pneumol Belg; 1976; 67(3-4):163-73. PubMed ID: 138353 [No Abstract] [Full Text] [Related] [Next] [New Search]